Clinical Trial Update: The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

View source ↗

Summary

A recruiting clinical trial evaluating molecular markers from predicted DNA to assess clinical outcomes in patients with urothelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Urothelial Neoplasm | Status: RECRUITING